US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Restore Sinus Spray

Reason Microbial contamination of Non-Sterile Products

Biomic Sciences, LLC dba ION Intelligence of Nature D-0069-2024
Class II · Moderate risk Terminated

ION* Sinus Support Nasal Spray

Reason Microbial contamination of Non-Sterile Products

Biomic Sciences, LLC dba ION Intelligence of Nature D-0068-2024
Class II · Moderate risk Ongoing

Gynazole-1

Reason Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.

Padagis US LLC D-0081-2024
Class II · Moderate risk Ongoing

Triamcinolone Acetonide Injectable Suspension

Reason Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.

Eugia US LLC NDC 55150-385-01 D-0041-2024
Class II · Moderate risk Terminated

HYDROmorphone in dextrose 5%

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0032-2024
Class II · Moderate risk Terminated

HYDROmorphone in dextrose 5%

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0030-2024
Class II · Moderate risk Terminated

HYDROmorphone in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2011-1 D-0029-2024
Class II · Moderate risk Terminated

HYDROmorphone in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2010-2 D-0028-2024
Class II · Moderate risk Terminated

succinylcholine

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-6011-2 D-0026-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0025-2024
Class II · Moderate risk Terminated

fentaNYL in dextrose 5%

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0024-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0023-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0022-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0021-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0020-2024
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc D-0019-2024
Class II · Moderate risk Terminated

midazolam in dextrose 5%

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-4036-1 D-0018-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2074-1 D-0014-2024
Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2071-5 D-0013-2024